FDA — authorised 20 July 1984
- Application: NDA018895
- Marketing authorisation holder: HOSPIRA
- Local brand name: TPN ELECTROLYTES IN PLASTIC CONTAINER
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Plegisol In Plastic Container on 20 July 1984
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 20 July 1984; FDA has authorised it; FDA has authorised it.
HOSPIRA holds the US marketing authorisation.